Effect of bacterial products on neutrophil chemotaxis.
Kalmar
J R
JR
Department of Periodontology, Eastman Dental Center, Rochester, New York 14620.
Van Dyke
T E
TE
D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology*; D002630:Chemotactic Factors / Q000494:pharmacology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D015936:Complement C5a / Q000494:pharmacology; D005374:Filtration / Q000379:methods; D006168:Guinea Pigs; D006801:Humans; D007202:Indicators and Reagents; D007975:Leukotriene B4 / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D010972:Platelet Activating Factor / Q000494:pharmacology; D012685:Sepharose
D001427:Bacterial Toxins; D002630:Chemotactic Factors; D007202:Indicators and Reagents; D008070:Lipopolysaccharides; D010972:Platelet Activating Factor; D007975:Leukotriene B4; D015936:Complement C5a; D012685:Sepharose